sur NOVACYT (EPA:ALNOV)
Dr. Ian Gilham Joins Novacyt as Non-Executive Director
Novacyt S.A., an international molecular diagnostics company, has announced the appointment of Dr. Ian Gilham as a Non-Executive Director. His role becomes effective immediately, pending shareholder approval at the upcoming Annual General Meeting.
Dr. Gilham brings extensive experience from various AIM-listed life sciences companies. He's known for his contributions to research, development, and the commercialization of diagnostic products. Currently, he holds executive roles in multiple companies, including Genedrive PLC and LifeArc.
CEO Lyn Rees expressed enthusiasm for Dr. Gilham's appointment, citing his valuable expertise to enhance Novacyt's strategic direction. The decision aligns with Novacyt's commitment to strengthening its board as it optimizes its operations and growth plans.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NOVACYT